Stephens Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.09M | Sell |
335,032
-8,393
| -2% | -$220K | 0.09% | 215 |
|
|
2026
Q1 | $9.73M | Buy |
343,425
+16,157
| +5% | +$430K | 0.12% | 174 |
|
|
2025
Q4 | $8.15M | Sell |
327,268
-35,698
| -10% | -$900K | 0.1% | 198 |
|
|
2025
Q3 | $9.27M | Sell |
362,966
-1,130
| -0.3% | -$27.9K | 0.12% | 181 |
|
|
2025
Q2 | $8.83M | Buy |
364,096
+728
| +0.2% | +$17K | 0.12% | 173 |
|
|
2025
Q1 | $9.21M | Buy |
363,368
+16,489
| +5% | +$431K | 0.13% | 165 |
|
|
2024
Q4 | $9.2M | Sell |
346,879
-31,410
| -8% | -$852K | 0.13% | 165 |
|
|
2024
Q3 | $10.9M | Sell |
378,289
-948
| -0.2% | -$27.7K | 0.16% | 151 |
|
|
2024
Q2 | $10.6M | Sell |
379,237
-42,544
| -10% | -$1.17M | 0.16% | 145 |
|
|
2024
Q1 | $11.7M | Sell |
421,781
-61,988
| -13% | -$1.72M | 0.18% | 139 |
|
|
2023
Q4 | $13.9M | Sell |
483,769
-12,998
| -3% | -$393K | 0.24% | 101 |
|
|
2023
Q3 | $16.5M | Sell |
496,767
-16,718
| -3% | -$591K | 0.32% | 77 |
|
|
2023
Q2 | $18.8M | Buy |
513,485
+7,677
| +2% | +$299K | 0.34% | 75 |
|
|
2023
Q1 | $20.6M | Buy |
505,808
+45,891
| +10% | +$1.98M | 0.4% | 66 |
|
|
2022
Q4 | $23.6M | Sell |
459,917
-32,897
| -7% | -$1.58M | 0.48% | 46 |
|
|
2022
Q3 | $21.6M | Buy |
492,814
+9,969
| +2% | +$484K | 0.46% | 49 |
|
|
2022
Q2 | $25.3M | Buy |
482,845
+6,192
| +1% | +$316K | 0.51% | 41 |
|
|
2022
Q1 | $24.7M | Sell |
476,653
-24,942
| -5% | -$1.29M | 0.4% | 56 |
|
|
2021
Q4 | $29.6M | Sell |
501,595
-528
| -0.1% | -$26.2K | 0.45% | 50 |
|
|
2021
Q3 | $21.6M | Sell |
502,123
-64,671
| -11% | -$2.86M | 0.33% | 74 |
|
|
2021
Q2 | $22.2M | Sell |
566,794
-12,506
| -2% | -$486K | 0.33% | 74 |
|
|
2021
Q1 | $21M | Buy |
579,300
+17,397
| +3% | +$618K | 0.34% | 73 |
|
|
2020
Q4 | $20.7M | Sell |
561,903
-23,900
| -4% | -$877K | 0.37% | 61 |
|
|
2020
Q3 | $20.4M | Sell |
585,803
-4,091
| -0.7% | -$143K | 0.4% | 56 |
|
|
2020
Q2 | $18.3M | Sell |
589,894
-23,369
| -4% | -$794K | 0.39% | 53 |
|
|
2020
Q1 | $19M | Sell |
613,263
-1,288
| -0.2% | -$43.9K | 0.51% | 35 |
|
|
2019
Q4 | $22.8M | Buy |
614,551
+53,068
| +9% | +$1.89M | 0.48% | 42 |
|
|
2019
Q3 | $19.1M | Buy |
561,483
+76,831
| +16% | +$2.79M | 0.42% | 55 |
|
|
2019
Q2 | $19.9M | Buy |
484,652
+46,679
| +11% | +$1.85M | 0.45% | 45 |
|
|
2019
Q1 | $17.6M | Buy |
437,973
+10,317
| +2% | +$413K | 0.42% | 54 |
|
|
2018
Q4 | $17.7M | Sell |
427,656
-75,432
| -15% | -$3.13M | 0.5% | 39 |
|
|
2018
Q3 | $21M | Buy |
503,088
+16,933
| +3% | +$652K | 0.52% | 31 |
|
|
2018
Q2 | $16.7M | Buy |
486,155
+41,319
| +9% | +$1.41M | 0.51% | 39 |
|
|
2018
Q1 | $15M | Buy |
444,836
+21,195
| +5% | +$729K | 0.56% | 35 |
|
|
2017
Q4 | $14.6M | Sell |
423,641
-2,995
| -0.7% | -$102K | 0.54% | 38 |
|
|
2017
Q3 | $14.5M | Buy |
426,636
+396
| +0.1% | +$12.7K | 0.52% | 36 |
|
|
2017
Q2 | $13.6M | Buy |
426,240
+4,975
| +1% | +$157K | 0.47% | 37 |
|
|
2017
Q1 | $13.7M | Buy |
421,265
+29,262
| +7% | +$923K | 0.5% | 35 |
|
|
2016
Q4 | $12.1M | Buy |
392,003
+18,603
| +5% | +$568K | 0.49% | 38 |
|
|
2016
Q3 | $12M | Buy |
373,400
+8,564
| +2% | +$286K | 0.53% | 34 |
|
|
2016
Q2 | $12.2M | Buy |
364,836
+34,842
| +11% | +$1.11M | 0.54% | 33 |
|
|
2016
Q1 | $9.28M | Buy |
329,994
+27,042
| +9% | +$772K | 0.45% | 40 |
|
|
2015
Q4 | $9.28M | Buy |
302,952
+39,236
| +15% | +$1.23M | 0.47% | 36 |
|
|
2015
Q3 | $7.86M | Buy |
263,716
+11,888
| +5% | +$381K | 0.41% | 44 |
|
|
2015
Q2 | $8.01M | Sell |
251,828
-867
| -0.3% | -$28.3K | 0.36% | 50 |
|
|
2015
Q1 | $8.34M | Buy |
252,695
+3,745
| +2% | +$119K | 0.38% | 44 |
|
|
2014
Q4 | $7.36M | Sell |
248,950
-6,554
| -3% | -$188K | 0.35% | 55 |
|
|
2014
Q3 | $7.17M | Buy |
255,504
+36,333
| +17% | +$1.02M | 0.35% | 50 |
|
|
2014
Q2 | $6.17M | Buy |
219,171
+9,672
| +5% | +$276K | 0.31% | 56 |
|
|
2014
Q1 | $6.38M | Buy |
209,499
+45,840
| +28% | +$1.37M | 0.35% | 47 |
|
|
2013
Q4 | $4.76M | Sell |
163,659
-7,653
| -4% | -$223K | 0.24% | 76 |
|
|
2013
Q3 | $4.67M | Sell |
171,312
-1,149
| -0.7% | -$31.3K | 0.25% | 68 |
|
|
2013
Q2 | $4.58M | Buy |
+172,461
| New | +$4.77M | 0.26% | 72 |
|
Other funds holding PFE
Stephens Inc's PFE Position: Q2 2026 in Review
Stephens Inc reduced its Pfizer (PFE) stake by 2.4% in Q2 2026, selling an estimated $220K and leaving 335,032 shares worth $8.09M. The position accounts for 0.09% of the portfolio, ranked #215.
Stephens Inc first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.6M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Stephens Inc held 335,032 shares of Pfizer worth $8.09M as of Q2 2026.
- Stephens Inc sold 8,393 Pfizer shares in Q2 2026, an estimated $220K.
- Pfizer made up 0.09% of Stephens Inc's portfolio in Q2 2026, its #215 holding.
- Stephens Inc first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Stephens Inc's Pfizer position peaked at $29.6M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.